RGEN

Conviction 66HealthcareScan · Mon, Jul 20, 2026

RGEN$145.61-1.11%

ResistanceSupportVol 14Insider sellCongress buyCongress sell

Vol MA14 823.29K

Apr 20May 6May 26Jun 11Jul 1Jul 20

REPLIGEN CORPBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.repligen.com ↗

Price145.61

Change-1.11%

Gap-0.40%

Rel volume1.23×

Avg volume1.02M

Avg $ vol144.28M

SMA 20141.34

SMA 50128.81

SMA 200140.16

Price vs 50+13.04%

Price vs 200+3.89%

MA stackmixed

50/200 cross—

Supertrendup · 132.95

RSI (14)60

MACD hist-0.05

MACD crossbear · 0d

Stoch %K / %D69 / 78

ADX (14)26

+DI / −DI28 / 17

RSI divergence—

MACD divergence—

ATR %+3.83%

ADR %4.13%

52w high172.26

52w low102.87

From 52w high-15.47%

Above 52w low+41.55%

New 52w highNo

SqueezeOff

Bollinger width17.64%

%B0.67

Donchian pos79.69%

Donchian high150.90

Donchian low124.85

AVWAP (52w high)129.45

vs AVWAP high+12.48%

AVWAP (52w low)128.05

vs AVWAP low+13.71%

OBV trendFlat

Chaikin MF (20)0.14

Today vs 20d1.23×

Avg vol (14d)823.29K

Avg vol (20d)1.02M

Avg $ vol (20d)144.28M

Market cap8.21B

RS 3m (vs SPY)+9.93%

RS 6m (vs SPY)-16.79%

RS line new highNo

Trend template6/8

Technical rank57.6

1 week+0.50%

1 month+9.03%

3 months+10.97%

6 months-9.94%

1 year+17.39%

YTD-11.40%

P/E167.99

P/B3.90

P/S58.15

P/FCF87.47

EPS0.8600

Div yield—

ROE2.32%

ROA1.67%

Debt/Eq0.26

Current9.20

EV/EBITDA61.07

Gross margin42.83%

Net margin34.62%

Rev growth35.10%

EPS growth291.64%

Price target165.36

Target upside13.56%

Analyst ratingBuy

Institutional127.95%

Ent. value8.18B

Revenue44.83M

Net income8.33M

Gross profit—

Free cash flow93.9M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out56.41M

Employees2K

ListedTue, Apr 29, 1986

Free float55.93M

Float %99.2%

Short interest6.05M

Days to cover4.7d

Short volume78.2%

Squeeze score68 / 100

Next earningsTue, Jul 28, 2026 · pre-mkt (8d)

EPS forecast$0.46 · 5 est

Last EPS vs est$0.48 vs $0.38

Last surprise+26.3% beat

Setup gradeB

Conviction66 / 100

Pattern quality—

Tech rank57.6 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance149.98

Support114.80

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 32 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 9 – Jun 10
2 scans
→
Breaking out now
Jun 11
1 scan
→
Setting up
Jun 12 – Jun 15
2 scans
→
Breaking out now
Jun 16
1 scan

Congress activity

Disclosed STOCK Act trades in RGEN · 6 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Lisa McClain house · MI · traded 2025-10-30	Sell	$1K–$15K	2025-10-30	2025-11-01	PDF
Lisa McClain house · MI · traded 2025-10-31	Sell	$1K–$15K	2025-10-31	2025-11-01	PDF
Lisa McClain house · R · MI · traded 2025-06-17	Sell	$1K–$15K	2025-06-17	2025-08-13	PDF
Lisa McClain house · R · MI · traded 2025-07-22	Buy	$1K–$15K	2025-07-22	2025-08-13	PDF
Lisa McClain house · R · MI · traded 2025-06-11	Buy	$1K–$15K	2025-06-11	2025-08-13	PDF
Jefferson Shreve house · R · IN · traded 2025-04-07	Sell	$15K–$50K	2025-04-07	2025-05-08	PDF

Insider activity

SEC Form 4 transactions in RGEN · 9 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Garland Jason K CFO · Common Stock · 2026-07-16	Sell	530	$80K	2026-07-16	2026-07-17
Konstantinov Konstantin Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18
DAWES KAREN A Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Konstantinov Konstantin Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Mhatre Rohin Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Pax Margaret Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
EGLINTON MANNER CARRIE Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
BARTHELEMY NICOLAS Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Madaus Martin D Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18
Pax Margaret Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18

SEC filings

EDGAR filings in RGEN · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.